August 2026: A cross-section of recent ICGEB scientific publications.
Read More



A living literature review by the ICGEB Regulatory Science Group proposes a comprehensive approach to risk reduction in managing gene drive technologies.
Read More

Organised within the framework of the B-INOC AFRICA project, supported by the Italian Ministry of Foreign Affairs and International Cooperation under the Mattei Plan for Africa, the B-INOC workshop highlighted how biotechnology research is being transformed into practical solutions with tangible socio-economic benefits across the continent.
Read More
The ICGEB community is celebrating a series of international recognitions awarded to members of the ICGEB Council of Scientific Advisers (CSA), whose scientific leadership continues to shape global research, innovation and collaboration.
Read More
The April 2026 edition of the ICGEB-DCVMN Technology Transfer for Vaccine Manufacturing course has been concluded, further reinforcing global efforts to strengthen vaccine manufacturing capacity in low- and middle-income countries.
Read More
A new wave of research is reshaping how biofertilisers and biostimulants are evaluated, beyond traditional yield measurements to focus on what really happens inside plants.
Read More
March 2026, ICGEB Director-General Lawrence Banks visits partner institutes and authorities in Argentina and Uruguay.
Read More
The ICGEB Trieste Molecular Pathology Group has collaborated on a study which has brougt to light a previously unknown neurodevelopmental disorder caused by mutations in SF3B3, a key component of the RNA splicing machinery.
Read More
Il gruppo di Patologia Molecolare dell’ICGEB di Trieste ha collaborato a uno studio che ha portato alla luce un disturbo neuro‑sviluppativo finora sconosciuto, causato da mutazioni nel gene SF3B3, un componente chiave del macchinario di splicing dell’RNA.
Read More
Following the launch of the BiotechNet II Project in January, a series of awareness workshops has taken place across East Africa.
Read More